Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.

LM Ruilope; R Agarwal; SD Anker; GL Bakris; G Filippatos; C Nowack; P Kolkhof; A Joseph; N Mentenich; B Pitt; FIGARO-DKD Investigators; Harald Sourij

doi:10.1159/000503712

Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.

LM Ruilope
, R Agarwal
, SD Anker
, GL Bakris
, G Filippatos
, C Nowack
, P Kolkhof
, A Joseph
, N Mentenich
, B Pitt
, FIGARO-DKD Investigators
, Harald Sourij (Kollaborator*in)

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

155 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	American Journal of Nephrology
DOIs	https://doi.org/10.1159/000503712
Publikationsstatus	Veröffentlicht - 2019

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

302 Klinische Medizin

Zugriff auf Dokument

10.1159/000503712

Andere Dateien und Links

Dieses zitieren

Ruilope, LM., Agarwal, R., Anker, SD., Bakris, GL., Filippatos, G., Nowack, C., Kolkhof, P., Joseph, A., Mentenich, N., Pitt, B., FIGARO-DKD Investigators, & Sourij, H. (2019). Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial. American Journal of Nephrology. https://doi.org/10.1159/000503712

@article{1bcf23dda4bf4dfe8c47b3ef78c60a0f,

title = "Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.",

author = "LM Ruilope and R Agarwal and SD Anker and GL Bakris and G Filippatos and C Nowack and P Kolkhof and A Joseph and N Mentenich and B Pitt and \{FIGARO-DKD Investigators\} and Harald Sourij",

year = "2019",

doi = "10.1159/000503712",

language = "English",

journal = "American Journal of Nephrology",

issn = "0250-8095",

publisher = "S. Karger AG",

}

Ruilope, LM, Agarwal, R, Anker, SD, Bakris, GL, Filippatos, G, Nowack, C, Kolkhof, P, Joseph, A, Mentenich, N, Pitt, B, FIGARO-DKD Investigators & Sourij, H 2019, 'Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.', American Journal of Nephrology. https://doi.org/10.1159/000503712

TY - JOUR

T1 - Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.

AU - Ruilope, LM

AU - Agarwal, R

AU - Anker, SD

AU - Bakris, GL

AU - Filippatos, G

AU - Nowack, C

AU - Kolkhof, P

AU - Joseph, A

AU - Mentenich, N

AU - Pitt, B

AU - FIGARO-DKD Investigators

A2 - Sourij, Harald

PY - 2019

Y1 - 2019

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000498619000003

UR - https://pubmed.ncbi.nlm.nih.gov/31665733

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC6889917

U2 - 10.1159/000503712

DO - 10.1159/000503712

M3 - Research article

C2 - 31665733

SN - 0250-8095

JO - American Journal of Nephrology

JF - American Journal of Nephrology

ER -